Gen-Probe Inc.

Mr. Phillips joined the Company in October 2008. He previously served as Vice President, Information Technology, for Favrille, where he was responsible for general information technology requirements as well as implementing electronic batch records for biologics manufacturing. Prior to joining Favrille, Mr. Phillips was Vice President of Information Technology at ChemNavigator, a cheminformatics systems and services provider. Mr. Phillips earned his B.S. in Computer Science from Rose-Hulman Institute of Technology.

Ph.D., M.D., Executive Vice President and Chief Scientist BA, (Mathematics) Western Reserve University; MS, (Microbiology) and Ph.D. (Molecular Genetics) University of Illinois; MD, University of Miami Dr. Kacian joined the Company in 1985 as Director of Medical and Scientific Affairs and until 1992 was primarily responsible for directing Research & Development and Regulatory Affairs. Dr. Kacian held various management positions with the Company and, in 2002, was promoted to Executive Vice President and Chief Scientist. From 1980 to 1985, Dr. Kacian was on the faculty of the Department of Pathology and Laboratory Medicine at the University of Pennsylvania and was Director of Clinical Microbiology at the Hospital of the University of Pennsylvania. He received an M.D. in 1978 from the University of Miami and did his internship and residency in laboratory medicine at Washington University and Barnes Hospital in St. Louis. Prior to attending medical school, Dr. Kacian received a B.A. in mathematics from Western Reserve University and an M.S. in microbiology and Ph.D. in molecular genetics from the University of Illinois and served on the faculty of the Department of Human Genetics and Development at Columbia University.

Senior Vice President, Clinical, Regulatory & Quality BS, (Biology) National Taiwan Normal University; Ph.D., (Zoology) Iowa State University Dr. Yang joined the Company in April 2007 as Vice President, Clinical, Regulatory and Quality. Dr. Yang brings over fifteen years experience in regulatory and clinical affairs, quality assurance and quality control. Most recently, Dr. Yang served as Vice President, Quality and Regulatory Affairs of Focus Diagnostics, owned by Quest Diagnostics, consisting of laboratory services, clinical trial and IVD production units with focus on infectious disease. Immediately prior, Dr. Yang held a variety of management positions in R&D, quality systems, diagnostic operations, and technical manufacturing. From 1987 to 1995, Dr. Yang served in quality control, biochemistry and allergy, and organic chemistry management positions at Diagnostic Products Corporation in Los Angeles. She has a B.S. in Biology from National Taiwan Normal University, Taipei, Taiwan and a Ph.D in Zoology from Iowa State University, Iowa. Dr. Yang is a Regulatory Affairs Certified (RAC), ISO9000 certified lead auditor as well as a Certified Quality Auditor (CQA).

Ms. De Walt joined the Company in January 2005. Prior to joining the Company, Ms. De Walt founded The HR Company in 1993 and served as its President and Principal Consultant providing professional human resources services to over 85 companies in a wide variety of industries. From 1988 to 1993, Ms. De Walt worked at Mitek Systems, Inc. as Director, Human Resources and subsequently Vice President, Human Resources. From 1987 to 1988, Ms. De Walt was Vice President, Human Resources of Imperial Savings Real Estate Lending Group. From 1984 to 1987, Ms. De Walt was Manager, Human Resources of Security Pacific Business Credit and Vice President, Human Resources of Security Pacific Business Finance. Ms. De Walt received an A.A. in liberal arts from St. Cloud State University and holds a Senior Professional In Resource Management certification.

Mr. Tardif joined the Company as Senior Vice President, Corporate Strategy in 2009. Prior to Gen-Probe, Mr. Tardif was a managing director in Morgan Stanley's healthcare investment banking group, focused on providing strategic and financial advisory services to diagnostics, life sciences tools and medical technology companies. Before joining Morgan Stanley in 2006, Mr. Tardif was an investment banker with Piper Jaffray from 2003 to 2006, and with Merrill Lynch from 1999 to 2003. He received his BA from Bishop's University in Quebec, his MBA from the University of British Columbia, and his Master of Science in Finance from the Boston College Carroll Graduate School of Management. Mr. Tardif holds a chartered financial analyst (CFA) designation.

Sr. Vice President, Operations BS, (Microbiology) San Diego State University; MBA, San Diego State University Ms. Ellerbrock joined the Company in November 2007. She previously served as Vice President, Operations at Invitrogen Corporation from August 2004 to November 2007, most recently for the Molecular Biology Business. Prior to joining Invitrogen, she held positions of increasing responsibility with GE Healthcare Bio-Sciences (formerly Amersham Biosciences). She served as Vice President, Operations from 2002 to 2004, and Vice President, Genomics Product Management, in 2002. Before joining Amersham in 1998, Ms. Ellerbrock was employed by Roche Molecular Systems and Gen-Probe. Ms. Ellerbrock received a B.S. in Microbiology and an M.B.A., both from San Diego State University.

Senior Vice President, General Counsel & Secretary BS, (Commerce) University of Virginia School of Commerce; JD, University of Virginia School of Law Mr. Bowen joined the Company in 1997 as Vice President, General Counsel and Assistant Secretary and was appointed Secretary in August 2002. Prior to joining the Company, he was a business litigation partner with the law firm of Luce, Forward, Hamilton & Scripps in San Diego, California. He received a B.S. in commerce and a J.D. from the University of Virginia.

Senior Vice President, Sales & Marketing BS, (Business Administration) Moravian College, Bethlehem, Pa. Mr. Kondor joined the Company in July 2005 as Vice President, Sales and Marketing. Mr. Kondor previously served as Vice President/General Manager — Genetic Analysis Business of Applied Biosystems (APPLERA), a life sciences company, from November 2004 to June 2005. From January 2003 to November 2004, Mr. Kondor served as Vice President and General Manager of Fisher Scientific, a life sciences company. From August 2001 to January 2003, Mr. Kondor served as Senior Vice President and General Manager of IGEN International, a biotechnology diagnostics company. From August 2000 to January 2001, Mr. Kondor served as Vice President, Worldwide Marketing & Sales of Avocet Medical Inc., a life sciences company. Prior to those positions, Mr. Kondor also held positions at Becton Dickinson Company, Biometric Imaging, Inc., the Diagnostics Division of Abbott Laboratories, and B. Braun Medical. Mr. Kondor received his B.S. in Business Administration from Moravian College in 1981.

Mr. Hansen joined Gen-Probe in December 2005 as Sr. Director, Domestic Sales. Prior to Gen-Probe, Mr. Hansen was with Fisher Scientific as Vice President of Sales for the Healthcare Division from June 2004 to December 2005 and the Diagnostic Division from August 2003 to June 2004. From October 2001 to August 2003, Mr. Hansen was with PSS World Medical, a distributor of physician office supplies, as Vice President of Sales. From June 1999 to July 2001, Mr. Hansen was Director of Sales for Avocet Medical, a life sciences company. He has also held sales and marketing positions at Spacelabs-Burdick and Quidel. Mr. Hansen received his BSBA from The University of Missouri in 1989 and his MBA from San Diego State University in 1992.

Ph.D., Vice President, Development Ph.D., (Biochemistry) University of Buenos Aires Dr. Giachetti joined the Company in 1995 to lead the technical team that developed the first FDA licensed blood-screening test for simultaneous detection of HIV-1 and HCV nucleic acids. From then she went on to hold positions of increased responsibility in the area of Blood Screening Products and her work directly contributed to the National Medal for Technology that Gen-Probe received in 2006. After her promotion to Senior Director, Product Development in 2004, her responsibilities extended to the area of Diagnostics. Prior to joining Gen-Probe, Dr. Giachetti worked as staff scientist at Genta and prior to that she performed basic research in virology, molecular virology and rapid viral evolution at UCSD and UCI. Dr. Giachetti has authored over 40 peer review publications and has made multiple presentations at national and international scientific meetings. She received her degrees in Clinical Analysis and Biochemistry from the School of Pharmacy and Biochemistry of the University of Buenos Aires and a Ph.D. in Biochemistry from the same University. She completed postdoctoral training at the University of California, San Diego, Department of Biology and at the University of California, Irvine, Department of Microbiology and Molecular Genetics.

Vice President, Marketing BA in biology and chemistry from Indiana University and an MBA from the University of Indianapolis. Mr. Eibel joined the Company in April 2007 as Vice President, Marketing. Prior to joining the Company, Mr. Eibel held various positions with Roche Molecular Diagnostics, including serving as Industrial Business Head, Business Development Group from August 2006 to April 2007, as Vice President, Genomics & Oncology, Global Product Marketing from January 2005 to July 2006, as Vice President, Corporate Accounts from November 2002 to December 2004 and as Area Service Director from April 2001 to October 2002. He received a B.A. in biology and chemistry from Indiana University and an M.B.A. from the University of Indianapolis.

Ph.D., Vice President, Research BS, University of California at Los Angeles (Chemistry); PhD, University of California at San Diego (Chemistry/Biochemistry) Dr. Arnold joined Gen-Probe most recently in September 2003 as Vice President, Research. Dr. Arnold also was associated with Gen-Probe from 1985 to 1989 as head of technology research. Previously, he held senior scientific and management positions at Molecular Biosystems, Genta, Synteni, Incyte Genomics, and Oasis Biosciences, where he was President and Chief Scientific Officer from October 2001 to September 2003. In addition, Dr. Arnold was a faculty member in the UCSD School of Medicine and a member of the UCSD Cancer Center. Dr. Arnold is an inventor or co-inventor on 36 issued U.S. patents and more than 140 issued and pending patents worldwide. In addition, he has authored more than 50 scientific publications. He received a B.S. in Chemistry from the University of California at Los Angeles and a Ph.D. in Chemistry/Biochemistry from the University of California at San Diego.

Mr. Blake joined the Company in October 2006 as Vice President, Instrument Systems. Mr. Blake has over twenty years of experience in instrument development. Prior to joining the Company, Mr. Blake worked as a Director of System Development in the Diagnostics Division of Bayer Corporation, a subsidiary of Bayer AG, a global health care, nutrition and innovative materials company, from March 2003 until October 2006, contributing to the Centaur CP, Centaur XP and Versant 440 projects. Prior to his employment with Bayer, Mr. Blake worked from June 2002 to March 2003 as a consultant for NPE Systems, Inc., a life sciences company. From January 2001 until June 2002, Mr. Blake served as Vice President, Product Development & Manufacturing for Varacel Corporation. Mr. Blake received a B.S. and M.S. in Electrical/Computer Engineering and Robots from Brown University.

Dr. Jemison is founder of BioSentient Corporation, a medical technology devices and services company focused on improving health and human performance through physiologic awareness and self-regulation. She is guiding the company in the design, development and marketing of leading-edge, NASA-patented ambulatory equipment that provides real-time, real-life physiologic monitoring and the means to control one's responses to their environment and stimuli. Dr. Jemison, the first woman of color to go into space, served six years as a NASA astronaut. She founded a technology consulting firm, The Jemison Group, and was an environmental studies professor at Dartmouth College, where she ran The Jemison Institute for Advancing Technologies in Developing Countries. A strong, committed national voice for science literacy, Dr. Jemison founded the international science camp The Earth We Share for students 12-16 years old, and serves as Bayer Corporation's national advocate for the Making Science Make Sense initiative. Before joining NASA, Dr. Jemison served as the Area Peace Corps Medical Officer for Sierra Leone and Liberia in West Africa, and practiced medicine in Los Angeles. She is a board member of Kimberly-Clark Corporation, Scholastic, Inc. and Valspar Corporation, and an A.D. White Professor-at-Large at Cornell University. Dr. Jemison is a member of the Institute of Medicine, an inductee of the National Women's Hall of Fame and the National Medical Association Hall of Fame, and a winner of the Kilby Science Award. She majored in chemical engineering and African and Afro-American Studies as an undergraduate at Stanford, and received her medical degree from Cornell.

Vice President, Investor Relations and Corporate Communications BS, Medill School of Journalism at Northwestern University; MBA, the Anderson School at UCLA Mr. Watts joined Gen-Probe in November of 2003 as Senior Director of Investor Relations and Corporate Communications. He added responsibility for Community Relations in 2004, Government Affairs in 2007, and Library Services in 2008. Before joining the Company, he was Director of Investor Relations and Corporate Communications at Ligand Pharmaceuticals, and Director of Strategy for Baxter BioScience. He also spent seven years at Merck & Co., Inc. in a variety of corporate communications, marketing support, public affairs and sales roles.

Armin Kessler - Armin M. Kessler served as Chief Operating Officer of Hoffmann-La Roche in Basel Switzerland from 1990 to 1995. Prior to being appointed COO, he held several senior positions at Hoffmann-La Roche, including head of the pharmaceutical and diagnostic divisions of the organization. Earlier positions in his career included Director of Pharmaceutical Marketing Worldwide for Sandoz (now Novartis) and President of Sandoz KK in Tokyo. He currently serves on the board of The Medicines Company, Gen_Probe and Spectrum Pharmaceuticals (formerly Neotherapeutics) and has served on the boards of Hoffmann-La Roche, Syntex and Genentech. He received a degree in Physics and Chemistry from Pretoria University in South Africa, a degree in Chemical Engineering from the University of Cape Town, South Africa, a Juris Doctorate from Seton Hall University, New Jersey, and Dr. h.c. in Business Administration from the University of Pretoria.

Dr. Martin joined Gilead Sciences in 1990 and currently serves as Chairman of the Board of Directors and Chief Executive Officer. He served as President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions in the antiviral chemistry division at Bristol-Myers Squibb and served for six years with Syntex Corporation, from 1978 until 1984. Dr. Martin is a member of the Presidential Advisory Council on HIV/AIDS and the Board of Directors of Gen-Probe Incorporated. He has been a member of the Board of Directors of the California Healthcare Institute since 2003, and currently serves as Chairman of the Board, a position he also held from 2005-2006. He served as President of the International Society for Antiviral Research from 1998-2000. In 2008, Dr. Martin was inducted into the National Academy of Engineering of the National Academies. Dr. Martin holds a PhD in organic chemistry from the University of Chicago and an MBA in marketing from Golden Gate University. He has received the Isbell Award from the American Chemical Society and the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research.

Raymond V. Dittamore has served as a Director of the Company since December 2002. Mr. Dittamore is a retired audit partner of Ernst & Young LLP, an international accounting firm. Mr. Dittamore retired in 2001 after 35 years of service with that firm, including 14 years as the managing partner of the firms San Diego office. Mr. Dittamore is also a director of Invitrogen Corporation, Gen-Probe Incorporated, and Digirad Corporation. Mr. Dittamore received a B.S. degree from San Diego State University.